CFP 4 Quality Impact Assessment (QIA) Policy
|
|
- Marybeth Johnson
- 5 years ago
- Views:
Transcription
1 CFP 4 Quality Impact Assessment (QIA) Policy Policy number CFP 4 Version 1.0 Approved by Name of author/originator Owner (director) Commissioning, Finance and Performance Committee Helen Collins, Associate Director of Quality and Improvement Vicky Stobbart, Executive Director for Nursing, Quality and Safeguarding Date of approval January 2017 Date of last review January 2017 Review to be completed by January 2018 To be next approved by January 2019 Page 1 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
2 Version control sheet Version Date Author Status Comment 1.0 December 2016 Helen Collins Draft 1.0 January 2017 Helen Collins Approved Approved by Commissioning, Finance and Performance Committee 1.0 March 2017 Helen Collins Approved Submitted to Quality and Clinical Governance Committee for information Page 2 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
3 Equality statement NHS Guildford and Waverley aims to design and implement services, policies and measures that meet the diverse needs of our service, population and workforce, ensuring that none are placed at a disadvantage over others. We take into account the Human Rights Act 1998 and promote equal opportunities for all. This document has been assessed to ensure that no employee receives less favourable treatment on the protected characteristics of their age, disability, sex (gender), gender reassignment, sexual orientation, marriage and civil partnership, race, religion or belief, pregnancy and maternity. Members of staff, volunteers or members of the public may request assistance with this policy if they have particular needs. If the member of staff has language difficulties and difficulty in understanding this policy, the use of an interpreter will be considered. We embrace the four staff pledges in the NHS Constitution. This policy is consistent with these pledges. See next page for an Equality Analysis of this policy. Page 3 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
4 Equality Analysis Equality analysis is a way of considering the effect on different groups protected from discrimination by the Equality Act, such as people of different ages. There are two reasons for this: to consider if there are any unintended consequences for some groups to consider if the policy will be fully effective for all target groups Name of Policy: QUALITY IMPACT ASSESSMENT POLICY Policy Ref: TO BE CONFIRMED Assessment conducted by (name, role): Helen Collins, Associate Director of Quality and Improvement Is this New? [Y ] Or Existing? [ ] Date of Analysis: 16 th February 2017 Directorate: Quality and Safeguarding Director s signature: Who is intended to follow this policy? Explain the aim of the policy as applied to this group. Employees of the Guildford and Waverley Clinical Commissioning Group or those who are host commissioned by them Who is intended to benefit from this policy? Explain the aim of the policy as applied to this group. Everyone who uses or is involved in delivering health and social care. The policy is far reaching. 1. Evidence considered. What data or other information have you used to evaluate if this policy is likely to have a positive or an adverse impact upon protected groups when implemented? None as it is designed to ensure that equality and quality are maximised at all times. 2. Consultation. Have you consulted people from protected groups? What were their views? No, as the policy is designed to enhance the quality of care for protected groups in conjunction with equality processes. 3. Promoting equality. Does this policy have a positive impact on equality? What evidence is there to support this? Could it do more? Positive impact as the policy is designed to enhance equality for protected groups 4. Identifying the adverse impact of policies Page 4 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
5 Identify any issues in the policy where equality characteristics require consideration for either those abiding by the policy or those the policy is aimed to benefit, based upon your research. a) People from different age groups: None b) Disabled people: None c) Women and men: None d) Religious people or those with strongly help philosophical beliefs: None e) Black and minority ethnic (BME) people: None f) Transgender people: None g) Lesbians, gay men and bisexual people: None h) Women who are pregnant or on maternity leave: None i) People who are married or in a civil partnership: None 5. Monitoring How will you monitor the impact of the policy on protected groups? Through quality alerts and complaints Page 5 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
6 Contents 1. Introduction and Policy Objective Legislative Framework/Core Standards Scope Definitions Roles and Responsibilities Procedure for assessing impact Frequency of assessment Raising concerns Implementation Monitoring Review, ratification and archiving Dissemination and publication Associated documents Bibliography Appendix 1: Risk Assessment Matrix Appendix 2: Initial Impact Screening Tool Appendix 3: Full Quality Impact Assessment Appendix 4: Quality Assurance Group Terms of Reference Appendix 5: Procedural Document Checklist for Approval Appendix 6: Compliance & Audit Table Page 6 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
7 1. Introduction and Policy Objective Guildford and Waverley Clinical Commissioning Group is committed to ensuring that commissioning decisions, business cases and any other business plans are appropriately evaluated for any potential impact on quality. The document outlines the process to be undertaken in order to assess the impact of any major change or policy decision and then ensure that adequate mitigations are put in place if necessary. 2. Legislative Framework/Core Standards The purpose of this document is to set out the responsibilities, process and format to be following when undertaking a quality impact assessment or where necessary a combined assessment also considering equality. The following legislation is relevant to this procedure: Equality Act 2010 Health and Social Care (Safety and Quality) Act 2015 Health and Social Care Act 2012 Health and Social Care Act 2008 (Regulated Activities) Regulations Scope This procedure relates only to impact assessments that are undertaken during the course of decision making on any of the following aspects of CCG business: Commissioning decisions Service redesign and pathway development Business case refusal Quality and cost improvement plans Changes to the infrastructure of the organisation Workforce redesign The above list is not exclusive or exhaustive and therefore when making any changes to service or policy an impact assessment should be considered. The remainder of this document will refer to this list collectively as business decisions. 4. Definitions 4.1 Quality Page 7 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
8 Quality can be defined as embracing the following three components: Patient Safety ensuring all appropriate measures are taken to avoid harm to patients Effectiveness of care providing the most appropriate treatments, interventions, support and services to patients at the right time Patient Experience ensuring that the patients experience is at the centre of the organisations approach to quality 4.2 Equality The Equality Act 2010 defines nine protected characteristics which the organisation must consider when making business decisions. The characteristics are as follows: Age - including specific ages and age groups Disability including cancer, HIV, multiple sclerosis and physical or mental impairment where the impairment has a substantial and long term adverse effect on the ability to carry out day-to-day activities Race including colour, nationality and ethnic or national origins Religion or belief including a lack of religion or belief, and where belief includes any religious or philosophical belief Sex Sexual orientation meaning a person s sexual orientation towards persons of the same sex, persons of the opposite sex and persons of either sex Gender re-assignment where people are proposing to undergo, are undergoing or have undergone a process for the purpose of reassigning the person s sex by changing physiological or other attributes of sex. Pregnancy and maternity Marriage and civil partnership If these are not considered and any risks mitigated, then quality is inevitably affected. This is why it is a key part of the Quality Impact Assessment. The organisation has an equality policy and impact assessment which should therefore be considered in its own right, and is referred to in the initial and full assessment including where to access the correct documentation and guidance. 4.3 Impact Assessment An impact assessment is a continuous process to ensure that possible or actual business decisions are assessed and the potential consequences on quality and equality are considered and any necessary mitigating actions are outlined in a uniformed way. Page 8 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
9 5. Roles and Responsibilities 5.1 Governing Body The Governing Body have overall responsibility for balancing necessary business decisions with quality and equality standards. They also have responsibility for providing assurance to external stakeholders. They will delegate the operational responsibility to the Executive Management Team (EMT). 5.2 Executive Management Team (EMT) The Executive Management Team is responsible for reviewing, at every meeting, the outcome of the Quality Assurance Group and the decisions they take on approvals for quality and equality impact assessments business decisions, where necessary, intervening if they feel the decision should be overturned. 5.3 Quality Assurance Group (QAG) The Quality Assurance Group will consist of the Executive Director of Nursing, Quality and Safeguarding, Associate Director of Quality, Quality and Safety Manager and two more members of the Senior Delivery Group (preferably Deputy Director of Governance and Compliance and Head of Partnership and Patient Engagement) to assigning approval of quality impact assessments of business decisions based on the levels of residual risk following mitigating action. They are responsible for keeping a log of assessments, and instructing a periodic audit of them to ensure no impact has actually occurred. 5.4 Senior Delivery Group (SDG) The members of the Senior Delivery Group are responsible for ensuring that business decisions are evaluated and locally approved for their impact on quality and/or equality. They are also responsible for ensuring they are submitted to the Quality Assurance Group for final approval. 5.5 Deputy Director of Governance and Compliance The Deputy Director of Governance and Compliance is responsible for the Trust s risk management processes and systems and ensuring a consistent approach to risk assessment. They are responsible for ensuring that any identified risks from the quality impact assessment are captured on the Trust s risk management system and escalated to the Corporate Risk Register as appropriate. 6. Procedure for assessing impact The flowchart below provides a step by step outline of the procedure for assessing impact. The scoring tool attached at Appendix 1 provides guidance on the criteria to consider when scoring each risk. Page 9 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
10 As part of the impact assessment, the assessor is required to consider any risks which should be added to the risk register. Any risks graded as 15 or above or with a consequence of five would automatically form part of the Trust s Corporate Risk Register and will be considered by the Audit Committee and the Quality and Clinical Governance Committee. Flowchart for Assessing / Reviewing / Monitoring Impact Initial screening of potential for impact to be undertaken by the manager or project lead (APPENDIX 2) Identification of impact in one or more areas? YES - Business decision put on hold and full impact assessment required and submitted for approval by QAG NO - Submit and gain approval from QAG and continue with business decision unless otherwise informed by QAG Full assessment of impact and identification of mitigating actions (APPENDIX 3) Escalation to appropriate member of SDG of any impact assessed as 'significant' to 'major' QAG to review and take approval on full impact assessment including a full review of the impact assessment, mitigating action plan and monitoring arrangements Notification from QAG to EMT of approval status of business decision and to business decision lead of outcome of review If all agreed by the EMT, the manager can fully proceed with the proposal and should commence implementation of the business decision 7. Frequency of assessment Impact assessment is a continuous process to help decision makers think through and understand the consequence of business decisions. Impact assessments must be undertaken as part of the development and proposal stage of developing plans and should also be reviewed on a regular (e.g. monthly) basis by the project leads, as part of reviewing the actual impact throughout the implementation stage and during the final review after the business decision has been implemented. 8. Raising concerns Where quality concerns which have potential to impact on patients are identified, the monitoring of quality outcomes should occur by the relevant lead. If there are further Page 10 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
11 concerns with the impact, the individual should follow the organisation s raising concerns policies which are accessible from the Human Resource Department. 9. Implementation This procedure is new for the organisation and will be implemented with immediate effect. All managers will be notified of the new requirements and a series of briefings will be arranged to support managers with this. The Quality Assurance Group will be formed and will begin meeting immediately following ratification of this document. Terms of Reference for the Quality Assurance Group will be submitted to the Executive Management Team for approval. 10. Monitoring Refer to appendix Review, ratification and archiving The procedure will be reviewed every 3 years or earlier if legislation, national policy or guidance changes are required to be considered. The review will then be subject to approval and re ratification. The author or Central Policy Officer is responsible for ensuring that archive copies of superseded working documents are retained in accordance with the organisation s record management policies. Persons requiring access to an archived policy must contact the central policy officer or the company secretary and provide them with the document title, name of author, ratification date and the version required. In addition, an electronic version of this is available on the organisation s intranet. 12. Dissemination and publication A copy of this policy will be uploaded to the organisation s intranet. The Head of Communications is responsible for organisational wide notification of the new procedure. The Associate Director of Quality is responsible for ensuring a communication is issued to all managers regarding the new procedure and is followed up with a series of presentations / drop in sessions. Page 11 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
12 13. Associated documents This procedure should be read in conjunction with the following organisational documents: Equality Impact Assessment Policy Risk Management Strategy and Policy Raising Concerns Policy 14. Bibliography Page 12 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
13 15. Appendix 1: Risk Assessment Matrix Step 1 Calculate the potential consequence: CONSEQU- ENCE DOMAIN NEGLIGIBLE MINOR MODERATE MAJOR CATASTROPH IC Minimal injury requiring no / minor interventi on Minor injury or illness, requiring first aid / minor medical treatment. Moderate injury requiring medical intervention Major injuries, or long term incapacity / disability Death Patient / Staff Safety No time off work required >3 days off work 4-14 days off work >14 days off work An event that impacts on a large number of patients RIDDOR reportable injury Multiple permanent injuries or irreversible health effects in a staff member Patient Experience Unsatisfactory patient experience not directly related to patient care Unsatisfactory patient experience readily resolvable Mismanageme nt of patient care Serious mismanageme nt of patient care Totally unsatisfactory patient outcome or experience Complaints Informal complaint resolved at local level Formal complaint where resolution achieved Formal complaint with potential to go to independent review Potential for more than one complaint / independent review Multiple complaints / inquest / ombudsman inquiry Page 13 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
14 Workforce Short-term low staffing (<1 day) which does not impact on quality Short-term low staffing (<1 day) which temporarily impacts on quality Unsafe staffing level or competence >1 day Unsafe staffing level or competence >5 days Ongoing unsafe staffing levels or competence Service / Business Interruption Loss / interruption more than 1 hour Loss / interruption more than 8 hours Loss / interruption more than 1 day Loss / interruption more than 1 week Permanent loss of service or facility Financial Small loss < 5000 Loss more than 0.1% of budget < 25K Loss more than 0.25% of budget 25K - < 100K Loss more than 0.5% of budget 100K - < 500K Loss more than 1% of budget > 500K S External Bodies / Inspections / Statutory Duties No or minimal recommendatio ns No or minimal noncompliance with standards / statutory duties Minor recommendatio ns given. Minor noncompliance with standards / statutory duties Reduced rating. Challenging recommendatio ns. Noncompliance with core standards / single moderate breach of standards / statutory duties Enforcement Action. Low rating. Critical report. Major / multiple noncompliance with core standards / statutory duties Prosecution. Zero Rating. Severely critical report Gross failure to meet national standards / statutory duties Adverse Publicity / Reputation Rumours Local media Short term. Minor effect on staff morale Local media Long term. Significant effect on staff morale National Media less than 3 days National media more than 3 days. MP Concern (Questions in House) Objectives / Projects Insignificant cost increase / schedule slippage. Barely noticeable reduction in scope or quality Less than 5% over budget / schedule slippage. Minor reduction in quality / scope 5-10% over budget / schedule slippage. Reduction in scope or quality 10-25% over budget / schedule slippage. Doesn t meet secondary objectives More than 25% over budget / schedule slippage. Doesn t meet primary objectives Page 14 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
15 Step 2 Calculate the potential likelihood: LIKELIHOOD Likeliho od Descript or Likelihood Examples CONSEQUENCE Rare Difficult to believe that this will ever happen/ recur Unlikely Do not expect it to happen/recur, but it may Possible It is possible that it may occur/recur Likely Is likely to occur/recur but is not a persistent issue Almost Certain Will almost certainly occur/recur and could be a persistent issue Step 3 Calculate overall risk score (consequence x likelihood): Low Risk Moderate Significant Major Risk 1-3 Risk Risk Page 15 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
16 16. Appendix 2: Initial Impact Screening Tool Please submit this initial screening assessment with the full details of the business decision to the Associate Director of Quality and Improvement. Full contact details of this person are available from the Administration team. Does the business decision directly affect patients or their families/carers? No Area of Quality Positive Impact Negative Impact No Impact Duty of Quality Compliance with NHS Constitution Impact on partner organisations and any aspect of shared risk Impact on organisations duty to safeguard children and vulnerable adults Impact on other services within the organisation List any other risk indicators relevant to the Duty of Quality Patient Safety Impact on patient safety Impact on preventable harm Impact on reliability of safety systems and processes Impact on systems and process for ensuring that the risk of healthcare acquired infections to patients is reduced Impact on clinical workforce capability and skills List any other risk indicators relevant to the Patient Safety Patient Experience Impact on self- reported experience of patients and service users in national / local surveys Impact on self- reported experience of patients and services users through the complaints process Impact on the self- reported experience of patients and service users through PALS contacts Impact on patient choice Impact on patient access Impact on the commitment to provide individualised care List any other risk indicators relevant to Patient Experience Page 16 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
17 Clinical Effectiveness Impact on the implementation of evidence based practice Impact on clinical outcomes Impact on clinical leadership Impact on the full adoption of Best Care Impact on variations in care Impact on ensuring care is delivered in the most clinically and cost effective setting Impact on clinical engagement List any other risk indicators relevant to the Clinical Effectiveness Equality A full equality assessment must also be conducted. Guidance and appropriate forms are available via the CCG s intranet: /FormsTemp/Pages/default.aspx Please now submit this initial screening assessment with the full details of the business decision to the Associate Director of Quality and Improvement. Full contact details of this person are available from the Administration team. Page 17 of 27 CFP 4 Quality Impact Assessment (QIA) Policy
18 17. Appendix 3: Full Quality Impact Assessment Please submit this initial screening assessment with the full details of the business decision to the Associate Director of Quality and Improvement. Full contact details of this person are available from the Administration team. QUALITY IMPACT ASSESSMENT SUBJECT OF ASSESSMENT: TEAM: DIRECTORATE: REASON FOR PROPOSED CHANGE: DOES THE SUBJECT OF THE ASSESSMENT DIRECTLY IMPACT ON PATIENTS OR THEIR CARERS? PLEASE LIST ANY RELEVANT STANDARDS / REGULATORY / STATUTORY REQUIREMENTS AND CONFIRM THIS PROPOSAL COMPLIES WITH THESE NAME OF ASSESSOR: DATE: RISK INDICATORS POSITIV E IMPACT NEGATIV E LOCAL / TRUST IMPACT DESCRIPTIO N MITIGATED RAW RISK RISK MITIGATION STRATEGY C L Total C L Total MONITORING LEAD Duty of Quality Compliance with NHS Constitution Impact on partner organisations Page 18 of 27
19 and any aspect of shared risk Impact on organisations duty to safeguard children and vulnerable adults Impact on other services within the organisation List any other risk indicators relevant to the Duty of Quality TOTAL 0 Patient Safety Impact on patient safety Impact on preventable harm Impact on reliability of safety systems and processes Impact on systems and process for ensuring that the risk of healthcare acquired infections to patients is reduced Impact on clinical workforce capability and skills List any other risk indicators relevant to the Patient Safety TOTAL 0 Patient Experience Impact on self- reported experience of patients and service users in Page 19 of 27
20 national / local surveys Impact on self- reported experience of patients and services users through the complaints process Impact on the self- reported experience of patients and service users through PALS contacts Impact on patient choice Impact on patient access Impact on the commitment to provide individualised care List any other risk indicators relevant to Patient Experience TOTAL 0 Clinical Effectiveness Impact on the implementation of evidence based practice Impact on clinical outcomes Impact on clinical leadership Impact on the full adoption of Best Care Impact on variations in care Impact on ensuring care is delivered in the most clinically / cost effective way Page 20 of 27
21 List any other risk indicators relevant to the Clinical Effectiveness TOTAL 0 SUMMARY OUTCOME OF IMPACT ASSESSMENT (to be completed by the Quality Assurance Group) AREA OF QUALITY OVERALL RISK RATING Key Risks (based on mitigated score) Duty of Quality 0 Patient Safety 0 Patient Experience 0 Clinical Effectiveness 0 TOTAL 0 RECOMMENDATIONS: Please now submit this initial screening assessment with the full details of the project to the Associate Director of Quality and Improvement. Full contact details are available from the Administration team Page 21 of 27
22 18. Appendix 4: Quality Assurance Group Terms of Reference 1. Constitution/ purpose The Group is to be known as the Quality Assurance Group (the Group). The Group has the powers either specifically delegated in these terms of reference or the organisation s scheme of delegation. The Group s role is to oversee the Quality Impact Assessment (QIA) process and review all business decisions to ensure there have been appropriate identification, assessment and mitigation of any significant major impacts The Group is constituted as a sub group of the Governing Body with delegated authority to make recommendations to the Executive Management Team regarding the potential impact on quality and equality of business decisions being proposed. 2. Membership, Chairmanship and Quorum (a) Membership Executive Director of Nursing, Quality and Safeguarding (Chair) Associate Director of Quality and Improvement Quality and Safety Manager Two members of the Senior Delivery Group preferably those involved in equality assessments and risk management NB Members must send an appropriate deputy if they are unable to attend a meeting. (b) Chairmanship The Executive Director of Nursing, Quality and Safeguarding shall be the Chair of the Group. (c) Quorum A quorum shall be either the Executive Director of Nursing, Quality and Safeguarding plus two other members 3. Frequency of meetings Meetings shall be held fortnightly and members must attend at least 50 % of all meetings but should aim to attend all scheduled meetings. Page 22 of 27
23 4. Terms of authority The Group is authorised to investigate any activity within its Terms of Reference and to seek any information it requires from any employee and all employees are directed to cooperate with any requests made by the Group. The Group is authorised to reject any QIAs that do not meet the required standard of completion The Group is authorised by the Governing Body to obtain legal or other independent advice and to secure attendance of outsiders with relevant experience and expertise if it considers this necessary. The Group is authorised to provide advice and make recommendations to managers and staff regarding the QIA process The Group is authorised to amend the QIAs as they see fit and to complete the summary information for onward presentation and consideration by the Executive Management Team 5. Objectives The Group shall: Ensure all required information is available to them to enable a full and thorough assessment of quality and equality impacts can take place Ensure a consistent approach is applied to the assessment of quality and equality impacts Keep the QIA process under review and recommend changes where necessary Produce the summary information sheets for each proposal to highlight the key risks and mitigations for each and present the overall impact findings to the Executive Management Team Provide a regular report to the Executive Management Team and the Quality and Clinical Governance Committee on the QIA process and an overview of the outcomes. Provide recommendations to the decision making committee with regard to whether the proposal can be implemented whilst maintaining required quality and equality standards Ensure members of the Group are provided with appropriate risk management training to enable them to fulfil their functions effectively. Page 23 of 27
24 6. Accountability The Group s meetings will be formally recorded and submitted to Executive Management Team 7. Review of effectiveness On a quarterly basis the Group shall monitor its effectiveness as follows: Ensuring its objectives, accountability and reporting arrangements are effective and meet the Group s requirements. The programming and implementation of any action plans Membership and attendance record Quorum requirements Agreed by the Quality Assurance Group.. (Chair Person) Date Page 24 of 27
25 19. Appendix 5: Procedural Document Checklist for Approval Procedural document checklist for approval To be completed and attached to any document which guides practice when submitted to the appropriate committee for consideration and approval. Title of document being reviewed: Policy framework for the development and management of procedural documents A Is there a sponsoring director? 1. Title Is the title clear and unambiguous? Is it clear whether the document is a guideline, policy, protocol or standard? 2. Rationale Are reasons for development of the document stated? 3. Development Process Do you feel a reasonable attempt has been made to ensure relevant expertise has been used? Is there evidence of consultation with stakeholders and users? 4. Content Is the objective of the document clear? Is the target group clear and unambiguous? Are the intended outcomes described? 5. Evidence Base Is the type of evidence to support the document identified explicitly? Are key references cited? /No/ Unsure 6. Approval Does the document identify which committee/group will approve it? 7. Dissemination and Implementation Is there an outline/plan to identify how the document will be disseminated and implemented amongst the target group? Comments/Details Page 25 of 27
26 Procedural document checklist for approval To be completed and attached to any document which guides practice when submitted to the appropriate committee for consideration and approval. Title of document being reviewed: Policy framework for the development and management of procedural documents Please provide details. 8. Process for Monitoring Compliance Have specific, measurable, achievable, realistic and time-specific standards been detailed to monitor compliance with the document? 9. Review Date Is the review date identified? 10. Overall Responsibility for the Document Is it clear who will be responsible for implementing and reviewing the documentation i.e. role of author/originator? Director Approval /No/ Unsure Comments/Details On approval, please sign and date it and forward to the chair of the committee/group where it will receive final approval. Name Karen McDowell Date Signature Committee Approval On approval, Chair to sign and date. Name Dominic Wright Date 17/02/2017 Signature Page 26 of 27
27 20. Appendix 6: Compliance & Audit Table Standard Source of Assurance / Timescale Frequency Reporting To: Responsibility Where a potential quality / equality impact of a business decision is identified, a full impact assessment should be conducted and a summary outcome submitted to the Executive Management Team to support the request for a decision Scrutiny of papers for meetings and any business cases / policies submitted without the required supporting documents should be returned for completion before being progressed. Annually Commissioning, Performance and Finance Committee Chief Executive and Senior Management.. Risk registers contain appropriate risks in relation to the potential impact of business decisions Risk registers reviewed on a quarterly basis and presented to Quality and Clinical Governance Committee Annually Commissioning, Performance and Finance Committee Associate Director of Quality and Improvement All assessments judged as having significant to major impact must be referred to the Quality Assurance Group Minutes of the Quality Assurance Group Annually Commissioning, Performance and Finance Committee Associate Director of Quality and improvement Page 27 of 27
Quality and Equality Integrated Impact Assessment Policy
Subject: Quality and Equality Integrated Impact Assessment Policy Meeting: NHS MK CCG Shadow Board Date of Meeting: 2 October 2012 Report of: Alison Jamson, NHSMK&N Introduction NHS Milton Keynes Clinical
More informationQuality Impact Assessment Policy
Quality Impact Assessment Policy Date: February 2016 Version: 2.1 Review Due: February 2018 Reader information Reference Directorate Document purpose Q005 Quality The purpose of this policy is to set out
More informationThe following tables define the impact and likelihood scoring options and the resulting score: - Risk score. Category
LIKELIHO OD NHS Eastern Cheshire Clinical Commissioning Group: Quality Impact Assessment Tool v1 Overview This tool involves an initial assessment (stage 1) to quantify potential impacts (positive or negative)
More informationRisk Assessment Scoring and Matrix
Risk Assessment Scoring and Matrix Appendix 2 Consequence score (severity levels) and examples of descriptors 1 2 3 4 5 Domains Negligible Minor Moderate Major Catastrophic Impact on the safety of patients,
More informationTrust Quality Impact Assessment (QIA) Policy
Trust Quality Assessment (QIA) Policy Version: 5.0 Ratified by: Date ratified: Name of originator/author: Name of responsible committee/individual: Date issued: 1 September 2016 Review date: 1 September
More informationModerate injury requiring professional intervention. Requiring time off work for 4-14 days. Increase in length of hospital stay by 4-15 days
APPENDIX 1 SHCCG Risk Scoring Matrix Taken from NPSA Risk Matrix for Managers (January 2008) Table 1 Consequence scores Choose the most appropriate domain for the identified risk from the left hand side
More informationDocument Details Title
Document Details Title Quality and Equalities Impact Assessment (QEIA) Process Guidance Trust Ref No 2046-45852 Local Ref (optional) Main points the document This document explains the process for QEIA,
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationSafeguarding Adults, Children and Young People Policy. CCG Policy Reference: CLIN 7
Safeguarding Adults, Children and Young People Policy CCG Policy Reference: CLIN 7 Brief Description (max 50 words) Target Audience Action Required This policy sets out the principles by which the CCG
More informationImpact Assessment Policy. Document author Assured by Review cycle. 1. Introduction Policy Statement Purpose or Aim Scope...
Impact Assessment Policy Board library reference Document author Assured by Review cycle P132 Quality Impact Assessment Policy Quality and Standards Committee 3 Years This document is version controlled.
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationHealth and Safety Strategy
NHS Newcastle Gateshead Clinical Commissioning Group Health and Safety Strategy Document Status Equality Impact Assessment Document Ratified/Approved By Final No impact Quality, Safety and Risk Committee
More informationDrainage of Abdominal Ascites
Drainage of Abdominal Ascites Standard Operating Procedure (SOP) Prepared by: Cancer & Vascular Access Advanced Nurse Practitioner Presented to: Date: Care and Clinical Policies Group 18 January 2017 Cancer
More informationSAFEGUARDING CHILDEN POLICY. Policy Reference: Version: 1 Status: Approved
SAFEGUARDING CHILDEN POLICY Policy Reference: Version: 1 Status: Approved Type: Clinical Policy Policy applies to : All services within SCH Serco Policy applies to (staff groups): All SCH Serco staff Policy
More informationExecutive Director of Nursing and Chief Operating Officer
Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationNovember NHS Rushcliffe CCG Assurance Framework
November 2015 NHS Rushcliffe CCG Assurance Framework ASSURANCE FRAMEWORK SUMMARY No. Lead & Sub Committee Date placed on Assurance Framework narrative Residual rating score L I rating in 19 March 2015
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationGCP Training for Research Staff. Document Number: 005
GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationSafeguarding Adults, Children and Young People Policy
Safeguarding Adults, Children and Young People Policy Policy number Version 1 Approved by Name of author/originator Owner (director) Date of approval Date of last review Quality and Clinical Governance
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationRISK MANAGEMENT STRATEGY
RISK MANAGEMENT STRATEGY Version Number 6.1 Version Date February 2018 Policy Owner Chief Executive Author Trust Risk and Patient Safety Manager First approval or date last reviewed The Risk Management
More informationDocument Title: Recruiting Process. Document Number: 011
Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationCARERS POLICY. All Associate Director of Patient Experience. Patient & Carers Experience Committee & Trust Management Committee
CARERS POLICY Department / Service: Originator: All Associate Director of Patient Experience Accountable Director: Chief Nursing Officer Approved by: Patient & Carers Experience Committee & Trust Management
More informationDocument Title: Version Control of Study Documents. Document Number: 023
Document Title: Version Control of Study Documents Document Number: 023 Version: 1.1 Ratified by: Committee Date ratified: 03 OCT 2017 Name of originator/author: Directorate: Department: Name of responsible
More informationNon Attendance (Did Not Attend-DNA ) Policy. Executive Director of Nursing and Chief Operating Officer
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Non Attendance (Did Not Attend-DNA) NTW(C)06 Executive Director of Nursing and Chief Operating Officer Ann Marshall
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationSOUTH EAST COAST AMBULANCE SERVICE NHS TRUST. General Risk Assessment Form
Assessment No. General Risk Assessment Form Completed by and role: Karen Dawes PTS Manager Initial assessment date: 14.09.12 Location of the risk: Vehicle General Assessment of GJ52 GZA Task / Hazard being
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationDocument Title: Training Records. Document Number: SOP 004
Document Title: Training Records Document Number: SOP 004 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical
More informationManagement of Diagnostic Testing and Screening Procedures Policy
Trust Policy Management of Diagnostic Testing and Screening Procedures Policy Purpose Date Version July 2012 2 The purpose of this policy is to ensure that all diagnostic and screening tests undertaken
More informationFramework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013
Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013 Information reader box NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information
More informationEAST & NORTH HERTS, HERTS VALLEYS CCGS SAFEGUARDING CHILDREN & LOOKED AFTER CHILDREN TRAINING STRATEGY
EAST & NORTH HERTS, HERTS VALLEYS CCGS Page 1 of 16 DOCUMENT CONTROL SHEET Document Owner: Directors of Nursing and Quality Document Author(s): Beverly Mukandi - Deputy Designated Nurse Safeguarding Children,
More informationNHS Greater Glasgow and Clyde Equality Impact Assessment Tool for Frontline Patient Services
NHS Greater Glasgow and Clyde Equality Impact Assessment Tool for Frontline Patient Services Equality Impact Assessment is a legal requirement and may be used as evidence for cases referred for further
More informationCCG CO16 Safeguarding Vulnerable Adults Policy
Corporate CCG CO16 Safeguarding Vulnerable Adults Policy Version Number Date Issued Review Date V1: 28/02/2013 28/02/2013 28/02/2014 Prepared By: Consultation Process: Formally Approved: 29/05/2013 Policy
More informationDate ratified November Review Date November This Policy supersedes the following document which must now be destroyed:
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy
More informationPOLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING
Policy on the handling of chemotherapy by staff who are pregnant/breastfeeding, v2.1 POLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING Version: 2.1 Ratified by: Date ratified:
More informationMoving and Handling Policy
Moving and Handling Policy Ratified Quality, Patient Safety and Risk / 16/04/2014 / 2014-40 Status Ratified Issued April 2014 Approved By Quality, Patient Safety and Risk Committee Consultation Quality,
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationInfection Prevention and Control: Audit Policy
Infection Prevention and Control: Audit Policy Document Status Version: 2.0 Approved DOCUMENT CHANGE HISTORY Initiated by Date Author Code of Practice September 2010 Dee May (Infection Control Specialist)
More informationPositive and Safe Management of Post incident Support and Debrief. Ron Weddle Deputy Director, Positive and Safe Care
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Positive and Safe Management of Post incident Support and Debrief NTW(C)13 Ron Weddle Deputy Director, Positive
More informationThe following tables define the impact and likelihood scoring options and the resulting score: - Risk score. Category
DRAFT Wirral Clinical Commissioning Group: Quality Assessment Tool v1 Overview This tool involves an initial assessment (stage 1) to quantify potential impacts (positive or negative) on from any proposal
More informationDISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY
Document Title: DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY Document Reference/ Register no: 18015 Version Number: 1.0 Document type: Policy To be followed by: Cervical Screening Provider
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationEquality and Diversity
Equality and Diversity Vision Statement Yasmin Mahmood Senior Associate Equality and Diversity May 2016 page 1/9 Introduction NHS Merton CCG is committed to ensuring equality, diversity and inclusion are
More informationNHS Continuing Healthcare Service Provider and Local Authority NHS Continuing Healthcare Inter-agency Disputes Policy
NHS Continuing Healthcare Service Provider and Local Authority NHS Continuing Healthcare Inter-agency Disputes Policy Reference No: CG056 Version: Version 0. 6 Ratified by: SWL CCG Governing Body Date
More informationDate 4 th September 2015 Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate Director of Quality Laura Rowe, Compliance Manager
TB 099/15 Meeting title Report title Trust Board Risk Management Strategy Date 4 th September 2015 Lead director Report author FOI status Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate
More informationNew Clinical Interventional Procedures Policy
New Clinical Interventional Procedures Policy Policy Title: Executive Summary: New Clinical Interventional Procedures Policy This document sets out East Cheshire NHS Trust s policy to ensure compliance
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Version No: 5.0 Effective From: 7 September 2017 Expiry Date: 31 August 2018 Date Ratified: 30 August 2017 Ratified By: Executive Team 1 Introduction
More informationPrimary Care Quality Assurance Framework (Medical Services)
PCC/15/021 Primary Care Quality Assurance Framework (Medical Services) 1.0 Introduction: From the 1 April 2015 the responsibility for monitoring quality and responding to concerns arising from General
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationProcedure for the Management of Incidents and Serious Incidents
Procedure for the Management of Incidents and Serious Incidents This Procedure outlines the key actions staff should undertake in the management of incident and Serious Incidents occurring in NHS Lambeth
More informationMORTALITY REVIEW POLICY
MORTALITY REVIEW POLICY Version 1.3 Version Date July 2017 Policy Owner Medical Director Author Associate Director of Patient Safety & Quality First approval or date last reviewed July 2017 Staff/Groups
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance
The Newcastle upon Tyne Hospitals NHS Foundation Trust Patient Choice Directive Policy & Guidance Version No.: 2.1 Effective From: 26 August 2014 Expiry Date: 26 August 2016 Date Ratified: 17 June 2014
More informationSerious Incident Management Policy
Serious Incident Management Policy Standard Operating Procedure Version Version 2 Implementation Date 01 November 2017 Review Date 31 October 2019 St Helens CCG Serious Incident Management Policy Approved
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationNURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015
NURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015 This policy supersedes all previous policies for Nurses Holding Power Section 5(4) MHA 1983. 1 Policy title Nurses Holding Power Section
More informationQuality and Governance Committee. Terms of Reference
Quality and Governance Committee Terms of Reference 1. Constitution 1.1 The Clinical Commissioning Group s Governing Body hereby resolves to establish a Committee of the Governing Body known as the Quality
More informationHealth and Safety Policy
Health and Safety Policy NHS Leeds rth Clinical Commissioning Group NHS Leeds South and East Clinical Commissioning Group NHS Leeds West Clinical Commissioning Group Version: 2.1 Ratified by: NHS Leeds
More informationIt is essential that patients are aware of, and in agreement with, their referral to palliative care.
Title: Directorate: Responsible for review: Ratified by: CHRONIC HEART FAILURE REFERRAL TO PALLIATIVE CARE SERVCES Palliative Care Consultant in Palliative Care Care and Clinical Policies Group Ref No:
More informationSAFEGUARDING CHILDREN: SUPERVISION POLICY
SAFEGUARDING CHILDREN: SUPERVISION POLICY Primary Intranet Location Version Number Next Review Year Next Review Month Safeguarding 3 2020 April Current Author Author s Job Title Department Kay Crome Named
More informationDiagnostic Testing Procedures in Urodynamics V3.0
V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.
More informationMental Capacity Act and Deprivation of Liberty Safeguards Policy and Guidance for staff
Mental Capacity Act and Deprivation of Liberty Safeguards Policy and Guidance for staff APPROVED BY: Approved by Quality and Governance Committee September 2016 EFFECTIVE FROM: September 2016 REVIEW DATE:
More informationNORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY
PLEASE NOTE POLICY IS UNDER REVIEW NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY Target Audience Brief Description (max 50 words) Action Required Providers, Commissioners
More informationVersion Number Date Issued Review Date V1: 28/02/ /08/2014
Corporate CCG CO01 Access and Choice Policy Version Number Date Issued Review Date V1: 28/02/2013 31/08/2014 Prepared By: Consultation Process: Governance Lead, NHS South of Tyne and Wear Information Governance
More informationConsultant to Consultant Referral Policy
Consultant to Consultant Referral Policy Version Author Date Comments Approved by No V1.0 Mel Sims 19 January 2017 To be APPROVED Governing Body Reader information Reference Document purpose COM002 This
More informationPOLICY & PROCEDURE FOR INCIDENT REPORTING
POLICY & PROCEDURE FOR INCIDENT REPORTING APPROVED BY: South Gloucestershire Clinical Commissioning Group Quality and Governance Committee DATE February 2015 Date of Issue: 25 February 2015 Version No:
More informationHealth & Safety Policy. Author:
Title: Reference No: Owner: Author: Health & Safety Policy 0010/Corporate Chief Officer Competent Person for Health and Safety Ruth Nutbrown CMIOSH First Issued On: Governing Body 4 December 2013 Latest
More informationLone worker policy. Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead
Document level: Trustwide (TW) Code: GR33 Issue number: 3 Lone worker policy Lead executive Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead 01244 397618
More informationA list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact
The Newcastle upon Tyne Hospitals NHS Foundation Trust Code of Practice for Wound Care Company Representatives and Staff with whom they interact Version No.: 1.1 Effective From: 8 th January 2015 Expiry
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationPOLICY ON THE IMPLEMENTATION OF NICE GUID ANCE
POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE Document Type Corporate Policy Unique Identifier CO-019 Document Purpose To outline the process for the implementation and compliance with NICE guidance and
More informationPolicy on Governance Arrangements Relating to Medicines V2.0
V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters
More informationPOLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:
POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: PROVISION OF INFORMATION TO DETAINED PATIENTS Document Author Written By: Lead for Mental Health
More informationAdmission to Hospital under Part II of the Mental Health Act 1983 and Mental Capacity Act 2005 Deprivation of Liberty Safeguards.
Document level: Trustwide (TW) Code: MH3 Issue number: 6 Admission to Hospital under Part II of the Mental Health Act 1983 and Mental Capacity Act 2005 Deprivation of Liberty Safeguards. Lead executive
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for Monitoring of Delayed Transfers of Care Version No.: 2.2 Effective From: 17 March 2015 Expiry Date: 17 March 2018 Date Ratified: 25
More informationEquality Objectives
Equality Objectives 2015 2019 This document is available in alternative community languages and formats upon request, such as large print and electronically. Please contact the Equality, Diversity and
More informationTrust Board Meeting in Public: Wednesday 18 January 2017 TB Equality, Diversity and Inclusion Progress Report
Trust Board Meeting in Public: Wednesday 18 January 2017 Title Equality, Diversity and Inclusion Progress Report Status History For noting Further to receipt of the Equality, Diversity and Inclusion, Annual
More informationSafeguarding Adults Policy
Safeguarding Adults Policy Ratified Status Quality and Patient Safety Committee V2 Issued November 2015 Approved By Consultation Equality Impact Assessment Quality and Patient Safety Committee Safeguarding
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Central Alert System (CAS) Policy and Procedure
The Newcastle upon Tyne Hospitals NHS Foundation Trust Central Alert System (CAS) Policy and Procedure Version No.: 4.1 Effective From: 6 August 2013 Expiry Date: 6 August 2016 Date Ratified: 2 August
More informationRef No: 2135 Title: Liquidised food through enteral feeding tubes in the community (Paediatric SOP) Version No: 1. Date of Issue: 10 March 2017
Ref No: 2135 Title: Liquidised food through enteral feeding tubes in the community (Paediatric SOP) Version No: 1 Originating Organisation: University Hospitals Bristol Date of Issue: 10 March 2017 Next
More informationPolicy for the Management of Safety Alerts issued via the Central Alerting System (CAS)
Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS) Policy Title: Executive Summary: Policy for the Management of Safety Alerts issued via the Central Alerting System
More informationCommissioning for Quality Assurance and Improvement using an Appreciative Enquiry Approach Policy/Procedure December 2014
Commissioning for Quality Assurance and Improvement using an Appreciative Enquiry Approach Policy/Procedure December 2014 Insert heading depending on line length; please delete other cover options once
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationCOMPLAINTS POLICY. Head of Complaints & Customer Service Improvement
COMPLAINTS POLICY POLICY REFERENCE NUMBER CP2 VERSION NUMBER 1 REPLACES SEPT DOCUMENT CP2 REPLACES NEP DOCUMENT CRP7 KEY CHANGES FROM PREVIOUS Not applicable VERSION AUTHOR Head of Complaints & Customer
More informationPan Dorset Procedure for the Management of the Closure of a Care Home Supporting people in Dorset to lead healthier lives
NHS Dorset Clinical Commissioning Group Pan Dorset Procedure for the Management of the Closure of a Care Home Supporting people in Dorset to lead healthier lives 1 PREFACE The planned or imminent closure
More informationReview of Terms of Reference of Quality Assurance Committee
Review of Terms of Reference of Quality Assurance Committee Governing Body meeting 3 May 2018 H Author(s) Sponsor Director Purpose of Paper Sue Laing, Corporate Services Risk and Governance Manager Mandy
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust Advance Decision to Refuse Treatment Policy (Advanced Refusal of Treatment/ Previously known as Living Wills) Incorporating the Mental Capacity Act
More informationPolicy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013
Policy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013 Subject: Policy Number: 1 Ratified by: Policy for Failure to Bring/Attend and Cancellation of Children s Health
More informationSABP/INFORMATIONSECURITY- SUMMARY CARE RECORD ACCESS/0003
SABP/INFORMATIONSECURITY- SUMMARY CARE RECORD ACCESS/0003 PROCEDURE NAME REASON FOR PROCEDURE WHAT THE PROCEDURE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Summary Care Record Access Procedure Permission
More informationDid Not Attend (DNA) and Cancellation Policy and Operational Guidelines
Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines Document Number Version Ratified By & Date Name of Approving Body(s) & Date(s) FPE-004 V1 Safety and Effectiveness Sub-Committee
More informationCLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS
CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,
More informationNewborn Hearing Screening Programme Policy
Newborn Hearing Screening Programme Policy V3.0 December 2015 Page 1 of 16 Summary - Screening Pathway for Newborn Hearing Screening Newborn hearing screening Check eligibility Eligible for screening Not
More informationPerson/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729
Appendix 2 - Equality Impact Assessment - Thromboprophylaxis Policy for Adult In-Patients Section A: Assessment Name of Policy Thromboprophylaxis Policy for Adult In-Patients Person/persons conducting
More informationCan I Help You? V3.0 December 2013
Can I help you? Policy for the provision and management of patient feedback: comments, concerns or compliments, or complaints about NHS 24 and its services. Author: Patient Affairs Manager/ ADoN Clinical
More information